Search by Drug Name or NDC
NDC 70709-0062-30 TASCENSO ODT 0.25 mg/1 Details
TASCENSO ODT 0.25 mg/1
TASCENSO ODT is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cycle Pharmaceuticals Ltd. The primary component is FINGOLIMOD LAURYL SULFATE.
MedlinePlus Drug Summary
Fingolimod is used to prevent episodes of symptoms and slow the worsening of disability in adults and children 10 years of age and older with relapsing-remitting forms (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). Fingolimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.
Related Packages: 70709-0062-30Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Fingolimod
Product Information
NDC | 70709-0062 |
---|---|
Product ID | 70709-062_1bbc20be-48e4-41e4-8657-7024d4f2172e |
Associated GPIs | |
GCN Sequence Number | 083636 |
GCN Sequence Number Description | fingolimod lauryl sulfate TAB RAPDIS 0.25 MG ORAL |
HIC3 | H0E |
HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
GCN | 52637 |
HICL Sequence Number | 048165 |
HICL Sequence Number Description | FINGOLIMOD LAURYL SULFATE |
Brand/Generic | Brand |
Proprietary Name | TASCENSO ODT |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Fingolimod Lauryl Sulfate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, ORALLY DISINTEGRATING |
Route | ORAL |
Active Ingredient Strength | 0.25 |
Active Ingredient Units | mg/1 |
Substance Name | FINGOLIMOD LAURYL SULFATE |
Labeler Name | Cycle Pharmaceuticals Ltd |
Pharmaceutical Class | Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA214962 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70709-0062-30 (70709006230)
NDC Package Code | 70709-062-30 |
---|---|
Billing NDC | 70709006230 |
Package | 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Marketing Start Date | 2023-02-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |